UNITAID is an international organisation that invests in new ways to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, more affordably and more effectively.
UNITAID finds health solutions that show promise and invests in them to establish their viability so that partner organisations can make them widely available. Through calls for proposals, UNITAID identifies key partners and health technologies with the potential to alleviate the burden of HIV/AIDS, tuberculosis and malaria. Financial grants from UNITAID help to fast-track access and reduce costs of new more effective medicines, technologies and systems to combat these diseases.
UNITAID’s main donors are France, the United Kingdom, Brazil, Norway, Chile, the Republic of Korea, Mauritius, Madagascar and the Bill & Melinda Gates Foundation. A key source of income is innovative financing, specifically the international solidarity levy on airline tickets, currently implemented in 10 countries: Cameroon, Chile, Congo, France, Guinea, Madagascar, Mali, Mauritius, Niger and the Republic of Korea. Norway allocates part of its tax on carbon dioxide emissions from aviation to UNITAID.